GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MEDLEY Inc (FRA:3YV) » Definitions » Research & Development

MEDLEY (FRA:3YV) Research & Development : €0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is MEDLEY Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. MEDLEY's Research & Development for the three months ended in Mar. 2024 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was €0.0 Mil.

MEDLEY Research & Development Historical Data

The historical data trend for MEDLEY's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MEDLEY Research & Development Chart

MEDLEY Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
- - - - -

MEDLEY Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

MEDLEY Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MEDLEY  (FRA:3YV) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

MEDLEY Research & Development Related Terms

Thank you for viewing the detailed overview of MEDLEY's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

MEDLEY (FRA:3YV) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MEDLEY Inc (FRA:3YV) » Definitions » Research & Development
Comparable Companies
TSE:2175 TSE:4820 TSE:3733 TSE:2150 TSE:6078 TSE:9438 TSE:3902 TSE:4263 TSE:5038 TSE:3939 VEEV GEHC TSE:2413 HQY ASX:PME RCM TXG DOCS PGNY EVH
Traded in Other Exchanges
4480:Japan
Address
3-2-1 Roppongi, Minato-ku, 22nd Floor Sumitomo Fudosan Roppongi Grand Tower, Tokyo, JPN, 106-6222
Website
https://www.medley.jp
MEDLEY Inc is engaged in providing medical information service for patients, and nursing care, a nursing care information service for citizens resolving issues in the field of medical healthcare. It provides its services through two platforms, Recruitment Platform Business which provides human resource recruitment systems in the medical and healthcare field and related businesses; and Medical Platform Business that is a telemedicine system for both patients and medical institutions.

MEDLEY (FRA:3YV) Headlines

No Headlines